Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human GASP-1/WFIKKN2 Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems AF2070
This item is not returnable.
View return policy
Description
GASP-1/WFIKKN2 Polyclonal specifically detects GASP-1/WFIKKN2 in Human samples. It is validated for Western Blot, Immunoprecipitation, Neutralization.Specifications
GASP-1/WFIKKN2 | |
Polyclonal | |
Unconjugated | |
Q8TEU8 | |
WFIKKN2 | |
Mouse myeloma cell line NS0-derived recombinant human GASP-1/WFIKKN2 Leu35-His576 Accession # Q8TEU8 | |
100 μg | |
Primary | |
Detects human GASP-1/WFIKKN2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant human GASP-2 is observed. | |
Human | |
IgG |
Western Blot, Immunoprecipitation, Neutralization | |
LYOPH | |
Western Blot 0.1 ug/mL, Immunoprecipitation 25 ug/mL, Neutralization 18.9 ug/mL | |
GASP1, GASP-1, Growth and differentiation factor-associated serum protein 1, hGASP-1, WAP, follistatin, immunoglobulin, kunitz and NTR domain-containing-relatedprotein, WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2, WAP, FS, Ig, two KU and NTR module related protein, WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 2, WFIKKN2, WFIKKN-related protein, WFIKKNRP, WFIKKNRPmultivalent protease inhibitor protein | |
Goat | |
Affinity Purified | |
RUO | |
124857 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction